Apelin Alleviates High Fat Diet‐Induced Cardiac Remodeling and Myocardial Contractile Dysfunction: Role of Mirna‐133a

Asli Fahriye Ceylan Isik,Machender R. Kandadi,Jun Ren,Sreejayan Nair

DOI: https://doi.org/10.1096/fasebj.25.1_supplement.1085.2

2011-01-01

Abstract:Apelin is a novel adipokine which is thought to play a role in normal cardiovascular function and glucose homeostasis. This study was designed to examine the cardiac and metabolic effects of apelin in high fat diet-induced obesity. C57BL6 mice were randomly assigned to receive either high- (45% fat) (HF) or low- (10% fat) (LF) fat diets starting from their 5–6 weeks of age for 20 weeks. The mice were then randomly divided to receive apelin (0.17 mg/kg, i.p./day) or vehicle for 2 weeks following which they were subjected to cardiomyocyte function assessment. HF-diet compromised myocardial contractile function (fractional shortening, cardiomyocyte peak shortening, maximal velocity of shortening/relengthening and duration of relengthening) and intracellular Ca2+ handling, the effects of which were significantly attenuated by apelin treatment. Echocardiography revealed that increased left ventricular mass and wall thickness in HF-fed mice, which were mitigated by apelin treatment. Western blot demonstrated that apelin treatment reduces levels of hypertrophy-related proteins. HF-diet reduced expression of miR-133a, a regulator of cardiomyocyte hypertrophy, which was restored by apelin treatment. Our results suggest apelin may rescue HF-diet-induced cardiac hypertrophy and contractile dysfunction, which may at least in part be attributed to upregulation of miR-133a.